tebnow
Pharma & Medications/Fierce Pharma

Verily Health Launches AI-Powered App to Demystify Medical Jargon

Verily Health has introduced its new AI-powered app, Verily Me, aimed at simplifying complex medical terminology for patients. The launch is accompanied by a marketing campaign featuring two 30-second advertisements that are being broadcasted across national television, audio platforms, and social media channels. This initiative is significant as it addresses the common challenge many patients face in understanding medical jargon, which can lead to confusion and anxiety regarding their health conditions. By leveraging artificial intelligence, Verily Me seeks to provide users with clear explanations and insights into their medical information, thereby enhancing patient engagement and empowerment. The campaign is expected to reach a wide audience, potentially impacting millions of individuals who struggle with health literacy. As the healthcare landscape increasingly incorporates technology, tools like Verily Me could play a crucial role in bridging the communication gap between healthcare providers and patients, fostering better health outcomes.

AI in healthcare / patient engagement / health literacy / digital health / Verily Health

Health Tech

All →

Enhancing Operational Stability During EHR Downtime with Digital Continuity Frameworks

Electronic Health Record (EHR) downtime has become a frequent challenge for healthcare organizations, impacting operations and patient care significantly. As health systems increasingly rely on digital workflows, the need for effective downtime strategies has never been more critical. Traditional fallback methods, such as manual processes and checklists, are proving inadequate in the face of modern operational demands. This shift necessitates the adoption of a digital continuity framework that ensures seamless coordination and stability during EHR outages. The proposed digital continuity framework aims to maintain essential functions such as patient intake, documentation, visibility, and recovery, even when EHR systems are offline. By integrating this framework, healthcare organizations can mitigate the clinical, operational, financial, and compliance repercussions associated with EHR downtime. The framework not only supports immediate operational needs but also aligns with the evolving landscape of healthcare technology. As organizations consider implementing these strategies, it is crucial to recognize the limitations of traditional downtime models. The transition to a digital continuity layer represents a proactive approach to safeguarding patient care and operational integrity. Moving forward, healthcare leaders must prioritize the development and integration of these frameworks to enhance resilience against EHR disruptions, ensuring that patient care remains uninterrupted and efficient.

Healthcare IT News · 11h ago

Disease & Epidemiology

All →

Revolution Medicines' Daraxonrasib Shows Promising Survival Benefit in Advanced Pancreatic Cancer Study

Revolution Medicines has reported significant findings from a Phase 3 clinical trial of its experimental drug daraxonrasib for patients with advanced pancreatic adenocarcinoma. The study revealed that patients treated with daraxonrasib experienced a median survival of 13.2 months, compared to just 6.7 months for those receiving standard chemotherapy. This notable survival benefit could represent a breakthrough in the treatment of one of the most challenging cancers to manage, where current therapies have limited effectiveness and survival rates remain low. The implications of this study are profound, as pancreatic cancer is known for its aggressive nature and poor prognosis. The data from this trial may pave the way for daraxonrasib to receive expedited approval from the Food and Drug Administration (FDA), although Revolution Medicines has not specified a timeline for its application. The potential for a new treatment option could significantly impact patient outcomes and change the landscape of pancreatic cancer therapy. Experts, including Paul Oberstein from NYU Langone’s Perlmutter Cancer Center, have highlighted the importance of these findings in the context of ongoing challenges in treating pancreatic cancer. With the trial results indicating a substantial improvement in survival, the medical community is keenly awaiting further developments regarding the drug's regulatory approval and its availability for patients in need. As the situation evolves, healthcare professionals will be closely monitoring the progress of daraxonrasib and its potential role in clinical practice.

STAT News · 15h ago

FDA Considers Broader Use of Testosterone Therapy for Enhancing Libido

The FDA is exploring the potential expansion of testosterone therapy indications to include treatment for low libido, a condition that affects a significant portion of the male population. This consideration comes in light of ongoing discussions about the efficacy and safety of current testosterone treatments. Low libido can have profound effects on quality of life and mental health, making effective treatment options critical for those affected. Recent studies indicate that testosterone therapy may not only improve libido but also enhance overall well-being in men with clinically low testosterone levels. As the FDA reviews the data, healthcare professionals are urged to stay informed about the implications of these potential changes in treatment guidelines and the impact on patient care. The outcome of this review could lead to new therapeutic options for men experiencing low libido, thereby addressing an important aspect of men's health.

STAT News · 19h ago

Record Mortality Rates in ICE Detention Raise Concerns Over Health Oversight

A recent analysis published in JAMA reveals alarming mortality rates among individuals detained by Immigration and Customs Enforcement (ICE) during President Trump's second term. The study, which examined federal records from 2004 to 2026, found that at least 272 detainees died in custody, with the latest fiscal year showing the highest mortality rate in nearly two decades, surpassing even the spike observed during the COVID-19 pandemic. Notably, nearly half of these deaths were attributed to 'undetermined causes', raising significant concerns about the health and safety of detainees. The increase in mortality rates coincides with major policy changes implemented in 2025, including reduced oversight, expanded detention facilities, and delays in medical care. These changes have led to a deterioration in the conditions of detention, which may have contributed to the rising death toll. Historical data indicates that the implementation of medical standards during the Bush and Obama administrations resulted in fewer deaths, highlighting the importance of oversight in maintaining detainee health. This report underscores the urgent need for reform in ICE detention practices to ensure the health and safety of individuals in custody. As the mortality rates continue to climb, healthcare professionals and policymakers are called to address these issues and advocate for improved medical care and oversight within the detention system. The findings serve as a critical reminder of the intersection between immigration policy and public health, emphasizing the responsibility to protect vulnerable populations.

STAT News · 19h ago

Pharma & Medications

All →

Verily Health Launches AI-Powered App to Demystify Medical Jargon

Verily Health has introduced its new AI-powered app, Verily Me, aimed at simplifying complex medical terminology for patients. The launch is accompanied by a marketing campaign featuring two 30-second advertisements that are being broadcasted across national television, audio platforms, and social media channels. This initiative is significant as it addresses the common challenge many patients face in understanding medical jargon, which can lead to confusion and anxiety regarding their health conditions. By leveraging artificial intelligence, Verily Me seeks to provide users with clear explanations and insights into their medical information, thereby enhancing patient engagement and empowerment. The campaign is expected to reach a wide audience, potentially impacting millions of individuals who struggle with health literacy. As the healthcare landscape increasingly incorporates technology, tools like Verily Me could play a crucial role in bridging the communication gap between healthcare providers and patients, fostering better health outcomes.

Fierce Pharma

Clinical Research

All →

Innovative Gene-Editing Strategies Show Promise for Treating β-Hemoglobinopathies

Recent phase 1/2 clinical trials have demonstrated the potential of direct editing of HBG1 and HBG2 promoters as a novel approach to treating β-hemoglobinopathies, including sickle-cell disease and β-thalassemia. These inherited blood disorders arise from mutations in the HBB gene, leading to severe complications and organ damage. Current treatment options are limited, with allogeneic hematopoietic stem cell transplantation being the only curative method, which is constrained by donor matching requirements. The emergence of two autologous gene therapies has marked progress in the field, yet researchers are actively pursuing more efficient, precise, and safer treatment modalities. The new gene-editing techniques aim to address the underlying genetic causes of these disorders, potentially offering a broader, disease-agnostic solution. The significance of these findings lies in their ability to transform the treatment landscape for patients suffering from β-hemoglobinopathies, who often face lifelong health challenges. As the research progresses, the focus will shift towards refining these gene-editing strategies and conducting further trials to establish their efficacy and safety in larger patient populations. Healthcare professionals and researchers are encouraged to monitor these developments closely, as they may herald a new era in the management of these debilitating conditions.

Nature Medicine · 1d ago

Health Policy

All →

Trump Nominates Erica Schwartz as New CDC Director Amid Ongoing Health Policy Discussions

President Donald Trump has nominated Erica Schwartz, a former deputy surgeon general, to lead the Centers for Disease Control and Prevention (CDC). If confirmed by the Senate, Schwartz would become the agency's fourth director in just over a year. Schwartz is recognized for her support of vaccines and her involvement in the COVID-19 pandemic response, positioning her as a more traditional choice for the role. This nomination comes at a time when Health and Human Services Secretary Robert F. Kennedy Jr. is testifying before Congress regarding the administration's budget request, which has sparked discussions on various health issues including Medicaid fraud and vaccine policies. During the hearings, Kennedy acknowledged the safety of measles vaccination, marking a potential shift in his previously more skeptical stance. However, he maintained his position on the hepatitis B vaccine, advocating for the removal of the newborn dose recommendation. This week also saw discussions surrounding new studies that challenge claims made during the Trump administration regarding acetaminophen use during pregnancy and the impact of water fluoridation on cognitive function. The ongoing dialogue reflects broader concerns about health policy and vaccine safety, particularly as the midterm elections approach. The administration's efforts to engage with the Make America Healthy Again movement indicate a desire to address supporter concerns, although it remains uncertain whether these efforts will fully reconcile differences within the constituency. Additionally, KFF Health News has highlighted the implications of current immigration policies on the medical workforce, further complicating the healthcare landscape as the administration navigates these multifaceted issues.

KFF Health News · 14h ago

States Revise Guardianship Laws to Protect Immigrant Families from Foster Care Placement

In response to increasing family separations due to immigration enforcement, several states are updating their guardianship laws to better protect the children of immigrant parents who may be detained or deported. The lack of federal tracking on the fate of these children has raised concerns, as many are reportedly placed in foster care when no relatives can take them in. For instance, Oregon has seen cases where children were placed in foster care after being separated from their parents, a situation that had not occurred prior to last fall. This separation can lead to severe psychological impacts, including post-traumatic stress disorder, highlighting the urgency of addressing this issue. States like New Jersey are considering legislation that would allow parents to designate temporary guardians in the event of their detention, with similar laws already passed in Nevada and California. However, many immigrant parents remain hesitant to utilize these provisions due to fears that their personal information could be accessed by Immigration and Customs Enforcement (ICE), potentially leading to their own detention. This fear is compounded by reports of ICE using data from health agencies to target parents under the guise of family reunification. Legal experts emphasize that the ability to nominate a guardian can provide some relief to immigrant families facing the threat of separation. However, the complexities of the legal system, particularly regarding reunification from foster care, pose significant challenges. As states continue to navigate these changes, the focus remains on ensuring the safety and well-being of children caught in the crossfire of immigration enforcement policies.

KFF Health News · 14h ago

The Rise of AI Chatbots in Mental Health: Opportunities and Concerns

The increasing demand for mental health care has led to a surge in the use of AI chatbots as alternatives to traditional therapy. With self-reported poor mental health days rising by 25% since the 1990s and suicide rates reaching a high not seen in nearly 80 years, many individuals are turning to these digital tools for support. Users like Vince Lahey from Arizona find AI chatbots appealing due to their perceived non-judgmental nature and accessibility, often sharing personal issues that they might with a human therapist. However, a significant gap remains in the quality of care, as 40% of those receiving treatment are only getting minimally acceptable care, according to Tom Insel, former head of the National Institute of Mental Health. Polling data indicates that approximately 30% of young adults aged 18 to 29 have sought mental health advice from AI chatbots in the past year, with uninsured individuals being more likely to use these tools. Despite their popularity, many users do not follow up with licensed professionals, raising concerns about the potential for delayed care. The market for AI therapy apps is expanding, with around 45 identified in the Apple App Store, often marketed as cheaper alternatives to traditional therapy, although they come with disclaimers stating they do not provide medical advice or treatment. Experts warn that the lack of regulatory oversight allows these apps to misrepresent their capabilities, potentially misleading users about the nature of the care they receive. States like Nevada, Illinois, and California are beginning to implement regulations to prevent apps from claiming to be mental health professionals. The efficacy of these AI tools remains under scrutiny, with researchers noting a lack of robust clinical trials to support their effectiveness. As the FDA faces criticism for not providing clear guidelines for testing these products, the safety and effectiveness of AI chatbots in mental health care continue to be a pressing concern for healthcare professionals and patients alike.

KFF Health News · 22h ago